174 related articles for article (PubMed ID: 14758138)
1. Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma.
Bundow D; Aboulafia DM
Am J Clin Oncol; 2004 Feb; 27(1):81-4. PubMed ID: 14758138
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.
Kobayashi M; Takaori-Kondo A; Shindo K; Mizutani C; Ishikawa T; Uchiyama T
Intern Med; 2002 Dec; 41(12):1209-12. PubMed ID: 12521218
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
[TBL] [Abstract][Full Text] [Related]
4. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
Hsu CH; Chen MY; Cheng AL
Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
[TBL] [Abstract][Full Text] [Related]
7. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
8. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
Aboulafia DM
Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study.
Nannan Panday VR; Hoetelmans RM; van Heeswijk RP; Meenhorst PL; Inghels M; Mulder JW; Beijnen JH
Cancer Chemother Pharmacol; 1999; 43(6):516-9. PubMed ID: 10321513
[TBL] [Abstract][Full Text] [Related]
10. New therapies for the treatment of AIDS-related Kaposi sarcoma.
Dezube BJ
Curr Opin Oncol; 2000 Sep; 12(5):445-9. PubMed ID: 10975552
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
Welles L; Saville MW; Lietzau J; Pluda JM; Wyvill KM; Feuerstein I; Figg WD; Lush R; Odom J; Wilson WH; Fajardo MT; Humphrey RW; Feigal E; Tuck D; Steinberg SM; Broder S; Yarchoan R
J Clin Oncol; 1998 Mar; 16(3):1112-21. PubMed ID: 9508198
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
14. Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma.
Schwartz JD; Howard W; Scadden DT
AIDS; 1999 Feb; 13(2):283-4. PubMed ID: 10202837
[No Abstract] [Full Text] [Related]
15. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer agents. A new treatment for Kaposi's sarcoma?
TreatmentUpdate; 2002; 14(7):6-8. PubMed ID: 12400501
[No Abstract] [Full Text] [Related]
17. Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.
Kim SE; Jung Y; Oh TH; Kim UJ; Kang SJ; Jang HC; Park KH; Lee KH; Jung SI
BMC Cancer; 2018 Nov; 18(1):1080. PubMed ID: 30409111
[TBL] [Abstract][Full Text] [Related]
18. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
19. Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.
Cianfrocca M; Lee S; Von Roenn J; Rudek MA; Dezube BJ; Krown SE; Sparano JA
Cancer Chemother Pharmacol; 2011 Oct; 68(4):827-33. PubMed ID: 21207228
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
